Mastek Limited — Major Shareholding Notification 2021

Sep 21, 2021

Address: A-104 Manibhadra Enclave, Opp. Rajasthan Hospital, Shahibaug, Ahmedabad – 380 004

UMANG TEJKARAN NAHATA

September 20, 2021

To, BSE Limited, Corporate Relationship Department, 25thFloor, P J Towers, Dalal Street, Fort, Mumbai – 400001 Security Code: 523704	To, National Stock Exchange of India Ltd, Exchange Plaza, 5thFloor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051 Security Code: MASTEK

Dear Sir/Madam,

• Sub: Disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011

• Ref: Scheme of Arrangement ("Scheme") pursuant to the provisions of Sections 230 - 232 and other applicable provisions, if any, of the Companies Act, 2013, between Evolutionary Systems Private Limited (“ESPL” or “Demerged Company”) and Trans American Information Systems Private Limited (“TAISPL” or “Resulting Company 1”) and Mastek Limited (“MASTEK” or “Resulting Company 2”) and their respective shareholders and creditors

Pursuant to Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (hereinafter referred to as 'SAST Regulations') we wish to inform you that, we, in our capacity as the shareholders of ESPL, have acquired the equity shares of Mastek Limited, a listed company, pursuant to the Scheme.

ln this connection please find enclosed the disclosure as per Regulation 10(6) of the SAST Regulations.

Request you to kindly take this intimation on record and oblige.

Thanking you. Yours Faithfully,

---

Umang Tejkaran Nahata for himself and also on behalf of Ummed Singh Nahata, Rakesh Raman, Yashodhar Bhinde, Sunil Kothari

Date: September 20, 2021 Place: Ahmedabad

Address: A-104 Manibhadra Enclave, Opp. Rajasthan Hospital, Shahibaug, Ahmedabad – 380 004

UMANG TEJKARAN NAHATA

Format for Disclosures under Regulation 10(6) - Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI SAST Regulations

1.	Name of Target Company	Name of Target Company	Mastek Limited	Mastek Limited
2.	Name of the Acquirers		1. Umang Tejkaran Nahata 2. Ummed Singh Nahata 3. Rakesh Raman 4. Yashodhar Bhinde 5. Sunil Kothari 6. Sunil Kothari (as trustee for allotment of fractional shares)
3.	Name of the stock exchange where shares of the Target Company are listed		BSE Limited and National Stock Exchange of India Ltd
4.	Details of the transactions including rationale, if any, for the transfer/acquisition of shares		Scheme of arrangement between Evolutionary Systems Private Limited (“ESPL” or “Demerged Company”) and Trans American Information Systems Private Limited (“TAISPL” or “Resulting Company 1”) and Mastek Limited (“MASTEK” or “Resulting Company 2”) and their respective shareholders and creditors. The certified true copy of the National Company Law Tribunal Order dated September 14, 2021 (received on September 15, 2021), was filed with Registrar of Companies on September 15, 2021. Hence the effective date of the Scheme is September 15,2021.
5.	Relevant regulation under which acquirer is exempted from making open offer		10(1)(d)(ii)
6.	Whether disclosure of proposed acquisition was required to be made under Regulation 10(5) and if so, - Whether disclosure was made and whether it was made within the timeline specified under the Regulations		Not Applicable
7.	Details of Acquisition		Disclosures required to be made under Regulation 10(5)	Whether disclosures under Regulation 10(5) are actuallymade
	a.	Name of the Transferor / Seller	Not Applicable	Not Applicable
	b.	Date of Acquisition	NotApplicable	NotApplicable
	c.	Number of shares/voting rights in respect of the acquisitions from each person mentioned in 7(a) above	Not Applicable	Not Applicable
	d.	Total shares proposed to be acquired /actually acquired as a % of diluted share capital of Target Company	Not Applicable	Not Applicable
	e.	Price at which shares proposed to be acquired/ actually acquired	Not Applicable	Not Applicable
8.		Shareholding Details	Pre-Transaction	Post Transaction

UMANG TEJKARAN NAHATA

Address: A-104 Manibhadra Enclave, Opp. Rajasthan Hospital, Shahibaug, Ahmedabad – 380 004

			No. of Shares Held	% w.r.t total share capital of TC	No. of Shares Held	% w.r.t total share capital of TC
		Each Acquirer:
		- Umang Tejkaran Nahata	NIL	-	15,31,482	5.17
		- Ummed Singh Nahata	NIL	-	11,48,611	3.87
		- Rakesh Raman	NIL	-	11,48,611	3.87
		- Yashodhar Bhinde	NIL	-	2,03,294	0.69
		- Sunil Kothari	NIL	-	2,03,294	0.69
		- Sunil Kothari (as trustee for the allotment of fractional shares)	NIL	-	2	0.00
		Each Seller / Transferor	Not Applicable		Not Applicable

==> picture [149 x 49] intentionally omitted <==

________ Umang Tejkaran Nahata for himself and also on behalf of Ummed Singh Nahata, Rakesh Raman, Yashodhar Bhinde, Sunil Kothari

Date: September 20, 2021 Place: Ahmedabad